ACADIA Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (69)

Latest Posts

About This Stock More About This Stock
10 Monster Stock Market Predictions For The Week Of June 14
Article By: Michael J. Kramer
Sunday, June 13, 2021 1:22 PM EDT
The big question is what’s next for the S&P 500. Monday morning will likely decide what happens next. It would not be surprising to a reversion to the beginning of the wedge at 4070 over the next couple of weeks.
In this article: C, ICE, ACAD, AAPL, EWJ, SPY, TLT, XLF, DJT
Stocks Drop On May 4 As Taper And Rate Hike Fear Grow
Article By: Michael J. Kramer
Tuesday, May 4, 2021 10:17 PM EDT
Stocks finished the day lower despite an end-of-day surge, leaving the S&P 500 down roughly 70 bps, while the NASDAQ QQQ ​​​​​​​fell by 1.8%.
In this article: ACAD, BITCOMP, SQ, AMZN, SPX, QQQ
The Technology Sector Gets Hammered On March 8
Article By: Michael J. Kramer
Monday, March 8, 2021 10:17 PM EDT
It was a rough day for stocks, especially technology stocks. They continue to get hammered as rates push higher. Now, the dollar is starting to strengthening as well, and that could further complicate the situation.
In this article: ACAD, NVDA, ROKU, DIS, XLE, QQQ, IEF, SPY
Most Shorted Stock Continue To Push Higher On February 1
Article By: Michael J. Kramer
Monday, February 1, 2021 10:28 PM EDT
Stocks jumped on February 1, with the S&P 500 rising by around 1.6%, recovering from Friday’s losses.
In this article: GME, ACAD, IEF, SPX, TYX, WMT, COST
Stocks Drop On November 12 With No Stimulus Deal On The Horizon
Article By: Michael J. Kramer
Thursday, November 12, 2020 10:42 PM EDT
Stocks fell on November 12, with the S&P 500 declining by 1%, finishing off of its lows. Meanwhile, the Qs finished the day lower by about 50 bps. 
In this article: HD, PYPL, ACAD, NVDA, SPY

Latest Tweets for $ACAD

No tweets yet!


Key Catalysts For ACADIA Pharmaceuticals
John Doee 6/8/2020 3:46:48 AM

What do you think specifically has helped $ACAD thrive during the Pandemic? While they are focusing on the development of drugs unrelated to COVID-19, how were they able to thrive?

Sunday Trio Of Short Ideas
All Things Tech 8/28/2017 3:36:31 AM

100% agreement on $BWLD especially since it has been flat for months in a bullish market with more room to fall.

I disagree with $AMD. If AMD falls below the SMA200, absolutely short, but the Triple Bottom off 12.00 is a cause of concern + a previous ER beat + Q3 ER beat likely & sitting in oversold territory according to (MFI). $SOXX shows a Pennant as well.

$ACAD long-term is down, but short term is up. Above the SMA 20, 50 & 200.

Both AMD & ACAD is big risk little reward in my book unless the Days to Cover is a big enough window. Otherwise just not worth it in my book.

1 to 2 of 2 comments